American Academy of Addiction Psychiatry 2012 Self-Assessment ExaminationThis Self-Assessment’s Examination goal is to provide timely clinical updates on new developments in addiction psychiatry, help practicing psychiatrists prepare for recertification and serve as a tool for board review. Release Date: September 1, 2012 Expiration Date: September 1, 2015 The American Board of Psychiatry and Neurology has reviewed American Academy of Addiction Psychiatry 2012 Self-Assessment Examination 1 (AAAPSAE1) awarding 8 Category-1 Self Assessment CME Credits and has approved this program as part of a comprehensive Self-Assessment Program which is mandated by the ABMS as a necessary component of Maintenance of Certification. CME Accreditation This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the Warren Alpert Medical School of Brown University and American Academy of Addiction Psychiatry. The Warren Alpert Medical School of Brown University is accredited by the ACCME to provide continuing medical education for physicians.Credit Designation The Warren Alpert Medical School of Brown University designates this enduring material for a maximum of 8 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.Method of physician participation in the learning process This examination should be used as a study guide for completing a Maintenance Of Certification (MOC) Board Examination. In order to fulfill American Board of Psychiatry and Neurology (ABPN’s) requirement each physician should complete all 100 questions in the self-assessment examination and in order to receive AMA CME Category 1 credit the physician needs to receive a passing grade of 60%. The estimated time to complete the examination itself is 8 hours (3 hours completing the examination including studying research and materials; 5 hours review of responses, explanations, references, peer responses and selection of areas identified after the physician has taken the examination. This information will provide what the physician needs to further study required for MOC preparedness.) To receive a maximum of 8 AMA PRA Category 1 Credits™ the physician must: • Register and access the 100 multiple-choice question self-assessment examination addressing 18 subject areas. • Complete examination which is available on-line 24/7 with access up to three years and may be taken in one sitting or test-taker may log-in and log-out at will. Questions must be answered serially (i.e., no skipping). Previously answered questions will be available for revision at the very end of the examination before it is submitted and a final score is issued. • Receive a passing grade of at least 60% on the examination.• Review feedback section that includes the correct answers, an explanation of the correct answer, and references for further study and review. • Receive additional feedback from AAAP 2012 Self-Assessment Examination which will include percentage of peers taking the exam who answered each question correctly and a listing of additional CME courses available through the AAAP which will assist in preparation for MOC. Target audience This self-assessment examination is relevant for addiction psychiatrists, and practicing psychiatrists preparing for recertification. It may also serve as a tool for board review, for PGY-V residents, general psychiatry residents, and for all academic and treatment personnel to stay updated on the most recent trends in the addiction field. It might also be relevant to junior faculty and clinicians as well as experienced practitioners and is intended to help psychiatrists prepare for ABPN examination for subspecialty certification and recertification in Addiction Psychiatry.Educational Objectives At the conclusion of this CME activity, addiction psychiatrists should be able to: 1) Assess how s/he makes decisions in common clinical situations; where s/he is likely to error and then develop her/his own self-assessment program of improvement; 2) Increase her/his knowledge of the latest findings in the field of addiction psychiatry; 3) Expand her/his knowledge of substance use disorders; 4) Identify strengths and weaknesses in the practice of addiction psychiatry.
Disclosure Policy AAAP and the Brown CME Program aim to provide educational information that is balanced, independent, objective and free of bias and based on evidence. In order to resolve any identified Conflicts of Interest, disclosure information from all series planners and speakers is provided during the planning process to ensure resolution of any identified conflicts.The following developers and planning committee members have reported that they have no commercial relationships relevant to the content of this series to disclose: Elinore McCance-Katz, MD,PhD, Larissa Mooney, MD and AAAP CME/CPD Committee Members Larry Westreich, MD, Kevin Sevarino, MD, PhD, Steve Batki, MD, Tim Fong, MD, Patricia Recupero, MD, Kathryn Cates-Wessel, Miriam Giles and Maria Sullivan. This activity’s planning committee has determined that the speakers' disclosure information listed below poses no bias or conflict to this presentation: Frances Levin, MD is a consultant for GW Pharmaceuticals and receives study medication from US Worldmed and Michelle Lofwall, MD is a consultant for Orexo and is on the PCM Scientific Steering Committee. All speakers have been advised that any recommendations involving clinical medicine must be based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the care of patients. All scientific research referred to, reported, or used in the presentation must conform to the generally accepted standards of experimental design, data collection, and analysis. Speakers must inform the learners if their presentation will include discussion of unlabeled/investigational use of commercial products Privacy and Confidentiality Policy AAAP and the Brown CME Program value your privacy and confidentiality of the information you choose to share with us. The personal information as provided on this self-assessment examination will be used to track grading and provide feedback regarding peer responses. CME evaluations allow for issuance and tracking of CME credit certificates. This information may also be used to track aggregate responses to questions in activities and evaluations to inform the ongoing evaluation and improvement of our CME programs. Personal information collected from evaluations will not be shared with third parties. ADA Accommodation Statement AAAP and the Brown CME Program encourage persons with disabilities to participate in its programs and activities. If you anticipate needing any type of accommodation or have questions about this CME activity, please contact AAAP at 401-524-3076 or e-mail email@example.com.
The system requirements for participation include:
Copyright ©2012 American Academy of Addiction Psychiatry - All Rights Reserved
Cvent Online Event Registration Software | Copyright © 2000-2014 Cvent Inc. All rights reserved.